STAAR Surgical Announces Q2 2025 Earnings Conference Call and Webcast on August 6, 2025
PorAinvest
jueves, 31 de julio de 2025, 10:05 pm ET1 min de lectura
STAA--
The live webcast, which includes an option to pre-register, can be accessed at the STAAR website or via the provided link [1]. A webcast replay will be available for at least 90 days following the event.
STAAR Surgical, founded in 1982, specializes in vision correction solutions that reduce or eliminate the need for glasses or contact lenses. The company's EVO family of Implantable Collamer® Lenses (EVO ICL™) offers safe, long-term vision correction without removing corneal tissue or the eye's natural crystalline lens. With over 3 million ICLs sold in more than 75 countries, STAAR Surgical has established itself as a global leader in the IOL market.
The company operates research, development, manufacturing, and packaging facilities in California and Switzerland. For more information about ICLs, visit www.EVOICL.com, and for additional details about STAAR Surgical, visit www.staar.com.
Investors are encouraged to monitor the company's investor relations section at investors.staar.com for material non-public information and to follow the company's press releases, SEC filings, and public conference calls and webcasts.
References:
[1] https://www.stocktitan.net/news/STAA/staar-surgical-to-host-second-quarter-2025-earnings-conference-call-ufyhep4odaoj.html
[2] https://www.businesswire.com/news/home/20250731973063/en/STAAR-Surgical-to-Host-Second-Quarter-2025-Earnings-Conference-Call-and-Webcast-on-August-6-2025
STAAR Surgical will release Q2 2025 financial results on August 6, 2025, and host an earnings call and webcast at 4:30 p.m. ET. The company will discuss its financial results and business progress. The live webcast can be accessed at the STAAR website, and a replay will be available for at least 90 days. STAAR Surgical is the global leader in implantable phakic intraocular lenses, with a focus on vision correction solutions.
STAAR Surgical Company (NASDAQ: STAA), a leading global provider of implantable phakic intraocular lenses (IOLs), will release its financial results for the second quarter ended June 27, 2025, on Wednesday, August 6, 2025, after the market close. The company will also host an earnings call and webcast at 4:30 p.m. ET to discuss its financial performance and business progress.The live webcast, which includes an option to pre-register, can be accessed at the STAAR website or via the provided link [1]. A webcast replay will be available for at least 90 days following the event.
STAAR Surgical, founded in 1982, specializes in vision correction solutions that reduce or eliminate the need for glasses or contact lenses. The company's EVO family of Implantable Collamer® Lenses (EVO ICL™) offers safe, long-term vision correction without removing corneal tissue or the eye's natural crystalline lens. With over 3 million ICLs sold in more than 75 countries, STAAR Surgical has established itself as a global leader in the IOL market.
The company operates research, development, manufacturing, and packaging facilities in California and Switzerland. For more information about ICLs, visit www.EVOICL.com, and for additional details about STAAR Surgical, visit www.staar.com.
Investors are encouraged to monitor the company's investor relations section at investors.staar.com for material non-public information and to follow the company's press releases, SEC filings, and public conference calls and webcasts.
References:
[1] https://www.stocktitan.net/news/STAA/staar-surgical-to-host-second-quarter-2025-earnings-conference-call-ufyhep4odaoj.html
[2] https://www.businesswire.com/news/home/20250731973063/en/STAAR-Surgical-to-Host-Second-Quarter-2025-Earnings-Conference-Call-and-Webcast-on-August-6-2025

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios